Crossref
PD-1 Expression in Tumor-Infiltrating Lymphocytes as a Biomarker in Pancreatic Ductal Adenocarcinoma: An Immunohistochemical and Clinicopathological Correlation Study
The Egyptian Journal of Hospital Medicine · 01.07.2026 · 104 (1) · 4605-4613
DOI: 10.21608/ejhm.2026.522607 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.07.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). PD-1 Expression in Tumor-Infiltrating Lymphocytes as a Biomarker in Pancreatic Ductal Adenocarcinoma: An Immunohistochemical and Clinicopathological Correlation Study. The Egyptian Journal of Hospital Medicine, 104(1), 4605-4613. https://doi.org/10.21608/ejhm.2026.522607
Vancouver
PD-1 Expression in Tumor-Infiltrating Lymphocytes as a Biomarker in Pancreatic Ductal Adenocarcinoma: An Immunohistochemical and Clinicopathological Correlation Study. The Egyptian Journal of Hospital Medicine. 2026;104(1):4605-4613. doi:10.21608/ejhm.2026.522607
BibTeX
@article{euvimed2026,
title = {PD-1 Expression in Tumor-Infiltrating Lymphocytes as a Biomarker in Pancreatic Ductal Adenocarcinoma: An Immunohistochemical and Clinicopathological Correlation Study},
journal = {The Egyptian Journal of Hospital Medicine},
year = {2026},
volume = {104},
number = {1},
pages = {4605--4613},
doi = {10.21608/ejhm.2026.522607}
}
EUVIMED